APTX - Aptinyx Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Evanston,
United States
Type: Equity
APTX price evolution
APTX
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $44.75 | $56.38 | $66.76 | $85.37 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $47.76 | $64.03 | $73.95 | $92.14 |
| Long term investments | ||||
| Property, plant & equipment | $0.03 | $0.04 | $0.07 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.21 | $2.65 | $2.25 | $0.17 |
| Total investments | ||||
| Total assets | $47.96 | $66.68 | $76.2 | $92.31 |
| Current liabilities | ||||
| Accounts payable | $1.37 | $0.72 | $0.47 | $2.11 |
| Deferred revenue | ||||
| Short long term debt | $5.65 | $2.79 | ||
| Total current liabilities | $9.32 | $6.29 | $2.69 | $5.68 |
| Long term debt | $19.44 | $22.11 | $24.71 | $24.5 |
| Total noncurrent liabilities | $20.38 | $22.11 | $24.72 | $24.52 |
| Total debt | $25.1 | $24.9 | $24.71 | $24.5 |
| Total liabilities | $29.71 | $28.4 | $27.41 | $30.21 |
| Shareholders' equity | ||||
| Retained earnings | -$373.8 | -$352.74 | -$340.68 | -$325.38 |
| Other shareholder equity | ||||
| Total shareholder equity | $18.26 | $38.28 | $48.79 | $62.1 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $56.38 | $106.32 | $141.21 | $99.03 |
| Short term investments | ||||
| Net receivables | $0.26 | $0.44 | ||
| Inventory | ||||
| Total current assets | $64.03 | $114.74 | $149.6 | $105.11 |
| Long term investments | ||||
| Property, plant & equipment | $0.03 | $0.18 | $0.91 | $1.2 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $2.65 | $0.18 | $1 | $1.37 |
| Total investments | ||||
| Total assets | $66.68 | $114.93 | $150.61 | $106.48 |
| Current liabilities | ||||
| Accounts payable | $0.72 | $0.62 | $1.21 | $1.55 |
| Deferred revenue | ||||
| Short long term debt | $2.79 | |||
| Total current liabilities | $6.29 | $5.69 | $4.58 | $4.9 |
| Long term debt | $22.11 | $14.15 | ||
| Total noncurrent liabilities | $22.11 | $14.49 | $0.11 | $0.27 |
| Total debt | $24.9 | $14.15 | ||
| Total liabilities | $28.4 | $20.17 | $4.7 | $5.17 |
| Shareholders' equity | ||||
| Retained earnings | -$352.74 | -$287.89 | -$213 | -$162.95 |
| Other shareholder equity | ||||
| Total shareholder equity | $38.28 | $94.76 | $145.91 | $101.31 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $16.09 | $7.23 | $10.01 | $11.91 |
| Selling, general & administrative | $4.23 | $4.2 | $4.65 | $5.2 |
| Total operating expenses | $20.32 | $11.43 | $14.66 | $17.11 |
| Operating income | -$20.32 | -$11.43 | -$14.66 | -$17.11 |
| Income from continuing operations | ||||
| EBIT | -$20.04 | -$11.12 | -$14.45 | -$16.91 |
| Income tax expense | ||||
| Interest expense | $1.03 | $0.93 | $0.85 | $0.76 |
| Net income | ||||
| Net income | -$21.07 | -$12.05 | -$15.3 | -$17.67 |
| Income (for common shares) | -$21.07 | -$12.05 | -$15.3 | -$17.67 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1 | $1.56 | $3.67 | |
| Cost of revenue | ||||
| Gross Profit | $1 | $1.56 | $3.67 | |
| Operating activities | ||||
| Research & development | $42.75 | $55.44 | $32.84 | $44.33 |
| Selling, general & administrative | $19.82 | $20.09 | $19.49 | $18.95 |
| Total operating expenses | $62.57 | $75.53 | $52.33 | $63.28 |
| Operating income | -$62.57 | -$74.53 | -$50.77 | -$59.61 |
| Income from continuing operations | ||||
| EBIT | -$61.83 | -$74.89 | -$50.05 | -$57.41 |
| Income tax expense | ||||
| Interest expense | $3.02 | |||
| Net income | ||||
| Net income | -$64.85 | -$74.89 | -$50.05 | -$57.41 |
| Income (for common shares) | -$64.85 | -$74.89 | -$50.05 | -$57.41 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$21.07 | -$12.05 | -$15.3 | -$17.67 |
| Operating activities | ||||
| Depreciation | $0.03 | $0 | $0.03 | $0.05 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.04 | $1.54 | $2 | $2.28 |
| Total cash flows from operations | -$11.37 | -$10.38 | -$18.63 | -$14.76 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$0.27 | -$0 | -$0 | -$0.01 |
| Total cash flows from financing | -$0.27 | -$0 | -$0.08 | -$0.13 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$11.63 | -$10.38 | -$18.7 | -$14.89 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$64.85 | -$74.89 | -$50.05 | -$57.41 |
| Operating activities | ||||
| Depreciation | $0.12 | $0.53 | $0.42 | $0.46 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $8.17 | $9.72 | $9.98 | $9.04 |
| Total cash flows from operations | -$59.68 | -$63.42 | -$42.36 | -$52.09 |
| Investing activities | ||||
| Capital expenditures | $0.12 | -$0.21 | -$0.04 | |
| Investments | ||||
| Total cash flows from investing | $0.12 | -$0.21 | -$0.04 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $13.84 | $85.36 | $0.37 | |
| Net borrowings | $9.98 | $14.56 | ||
| Total cash flows from financing | $9.75 | $28.33 | $84.67 | $0.19 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$49.94 | -$34.98 | $42.1 | -$51.93 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$62.40M |
| EBIT | -$62.52M |
| Net Income | -$66.09M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -93.36% |
| ROE | -157.89% |
| Debt/Equity | 0.74 |
|---|---|
| Net debt/EBITDA | 0.24 |
| Current ratio | 5.12 |
| Quick ratio | 5.12 |